PhRMA Foundation Adherence Improvement Young Investigator Grant Program
Over the past 48 years, the PhRMA Foundation has helped thousands of scientists advance their careers and has inspired new generations to enter biopharmaceutical research. The early-career support provided by the PhRMA Foundation has been a catalyst for our scientists to become leaders in their organizations and fields. Our programs help build a larger pool of highly-trained researchers to meet the growing needs of academic institutions, the government and the research-intensive pharmaceutical industry. The PhRMA Foundation funds scientists at critical points in their research careers to support and reward innovat...
Source: ScanGrants feed - August 15, 2013 Category: Research Authors: PhRMA Foundation Source Type: funding
NASA Research and Technology Development to Support Crew Health and Performance in Space Exploration Missions
Funding Opportunity Number: NNJ13ZSA002N-FLAGSHIP Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 43.003Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: NASA-JSCClosing Date: Sep 04, 2014Award Ceiling: Expected Number of Awards: Creation Date: Aug 08, 2013Funding Opportunity Description: The National Aeronautics and Space Administration (NA...
Source: Grants.gov - August 11, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Differential Effects on Homozygous Twin Astronauts Associated with Differences in Exposure to Spaceflight Factors
Funding Opportunity Number: NNJ13ZSA002N-TWINS Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 43.003Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: NASA-JSCClosing Date: Sep 04, 2014Award Ceiling: Expected Number of Awards: Creation Date: Aug 08, 2013Funding Opportunity Description: The National Aeronautics and Space Administration (NASA)...
Source: Grants.gov - August 11, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
NASA Human Research Program Omnibus Opportunity
Funding Opportunity Number: NNJ13ZSA002N-OMNIBUS Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 43.003Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: NASA-JSCClosing Date: Sep 04, 2014Award Ceiling: Expected Number of Awards: Creation Date: Aug 08, 2013Funding Opportunity Description: The National Aeronautics and Space Administration (NAS...
Source: Grants.gov - August 11, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases Sponsored by the AAN and the American Brain Foundation and funded through the philanthropy of the Potamkin family. This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick's, Alzheimer's, and related diseases. Presentation Recipient is expected to present a 20-minute lecture during a scientific session at the 66th AAN Annual Meeting. Recipient will receive: Medallion and $100,000 prize Complimentary registration for 66th Annual Meeting Recogni...
Source: ScanGrants feed - August 1, 2013 Category: Research Authors: American Academy of Neurology/American Brain Foundation/Potamkin Family Source Type: funding
Human exploration research opportunities nasa research announcement
Funding Opportunity Number: NNJ13ZSA002N Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 43.003Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: NASA-JSCClosing Date: Sep 04, 2014Award Ceiling: $1,350,000Expected Number of Awards: Creation Date: Jul 15, 2013Funding Opportunity Description: The National Aeronautics and Space Administration (...
Source: Grants.gov - July 31, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
PhRMA Foundation Grants Program
Over the past 48 years, the PhRMA Foundation has helped thousands of scientists advance their careers and has inspired new generations to enter biopharmaceutical research. The early-career support provided by the PhRMA Foundation has been a catalyst for our scientists to become leaders in their organizations and fields. Our programs help build a larger pool of highly-trained researchers to meet the growing needs of academic institutions, the government and the research-intensive pharmaceutical industry. The PhRMA Foundation funds scientists at critical points in their research careers to support and reward innovat...
Source: ScanGrants feed - July 16, 2013 Category: Research Authors: PhRMA Foundation Source Type: funding
Request for Proposals: Creative Computational Approaches to Accelerate Drug Discovery for the Treatment and Prevention of Dementia
Current methods of drug discovery have had limited success at predicting clinical efficacy of investigational therapies in patients with Alzheimer’s disease and other age-related dementias. Computational modeling, systems biology and pharmacology, and translational bioinformatics represent a tremendous yet relatively under-developed opportunity to accelerate and improve this process particularly for dementias. The Alzheimer’s Drug Discovery Foundation (ADDF) program on Aging & Alzheimer’s Disease Prevention is requesting proposals for innovative computational approaches to map disease a...
Source: ScanGrants feed - June 4, 2013 Category: Research Authors: Alzheimer’s Drug Discovery Foundation Source Type: funding
DoD FY13 Prostate Cancer Laboratory-Clinical Transition Award
Funding Opportunity Number: W81XWH-13-PCRP-LCTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 09, 2013Award Ceiling: $0Expected Number of Awards: 2Creation Date: May 13, 2013Funding Opportunity Description: The PCRP Laboratory - Clinica...
Source: Grants.gov - May 16, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Gulf War Illness Investigator-Initiated Research Award
Funding Opportunity Number: W81XWH-13-GWIRP-IIRA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 18, 2013Award Ceiling: $0Expected Number of Awards: 3Creation Date: May 14, 2013Funding Opportunity Description: The GWIRP Investigator-Initi...
Source: Grants.gov - May 16, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Notice of Correction of Expiration Date for PAR-11-052 Mechanisms of Adverse Drug Reactions in Children (R03)
Notice NOT-HD-13-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2013 Category: Research Source Type: funding
Call for Nominations: Oscar B. Hunter Memorial Award in Therapeutics
The Oscar B. Hunter Memorial Award in Therapeutics was established in 1955 to honor individual scientists for outstanding contributions to clinical pharmacology and therapeutics. This award recognizes a meritorious career in drug research, excellence or contributions in direct patient care, and a distinguished teaching career. The Oscar B. Hunter Memorial Award in Therapeutics is the Society's premier award. The goal of the award is to honor a scientist for outstanding contributions to clinical pharmacology and therapeutics over the individual's professional life. Eligibility A nominee must be able...
Source: ScanGrants feed - May 8, 2013 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: Leon I. Goldberg Young Investigator Award
The Leon I. Goldberg Young Investigator Award was established in 1986 to honor a young scientist for accomplishments in the field of clinical pharmacology achieved early in his/her career. The goal of the Leon I. Goldberg Young Investigator Award is to encourage and recognize young scientists active in the field of clinical pharmacology. Eligibility There are no restrictions concerning the scientific field in which nominees have earned their doctoral degrees. Nominees must be no more than 45 years of age as of March 1 of the year in which the award is presented. Although it is encouraged, a nominee need no...
Source: ScanGrants feed - May 8, 2013 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: Gary Neil Prize for Innovation in Drug Development
The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several ...
Source: ScanGrants feed - May 8, 2013 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
